Condition: Treatment Resistant Depression · Sponsor: Abbott Medical Devices
The goal of this clinical trial is to evaluate the effectiveness and safety of bilateral stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain Stimulation (DBS) as an adjunctive treatment of non-psychotic unipolar Major Depressive Disorder (MDD) in adults.
This description comes directly from the study's public registry record.
Natalie Danovsky · +16517563842 · natalie.richardson@abbott.com
Lyndahl Himes · lyndahl.himes@abbott.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham - Dept. of Psychiatry | Birmingham, Alabama, United States | Recruiting |
| USC University Hospital | Los Angeles, California, United States | Recruiting |
| UCLA Department of Psychiatry | Los Angeles, California, United States | Recruiting |
| University of California at Davis | Sacramento, California, United States | Recruiting |
| USF Health | Tampa, Florida, United States | Recruiting |
| Emory University Hospital | Atlanta, Georgia, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Recruiting |
| University of Minnesota Medical Center Fairview | Minneapolis, Minnesota, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06423430